Xconomy | Boston - Business + Technology in the Exponential Economy

Spire Shines with $54.9M Solar Contract
Federal Judge Rules in Biogen Idec’s Favor, Sepracor Agrees to $2.8B Buyout, FDA Panel Endorses Gloucester Pharma Drug, & More Boston-Area Life Sciences News
GT Solar Sees Brighter IPO Skies; Pfizer, Merck, and Eli Lilly Back Boston Startup; GSI Group Beams out $360M for Excel Technology & More Deals News
GT Solar Wins $173M Contract with Korean Chemical Firm
GT Solar Lands Big Contract with Dutch Solar Panel Maker

Spire Sells Off Catheter Biz

Spire Corp. of Bedford, MA, said today it is divesting its hemodialysis catheter business in order to focus exclusively on making equipment for solar photovoltaic module manufacturing. Bard Access Systems is buying the catheter division for $15 million. “The divestiture of the hemodialysis catheter business at this time is clearly in Spire’s best strategic interest,” said Spire CEO Roger Little in a statement. “We continue to see tremendous opportunity in the solar market and can better capitalize on these opportunities with a more focused approach.”

Wade Roush is Xconomy's chief correspondent. You can e-mail him at wroush@xconomy.com, call him at (617) 252-7323, or follow him on Twitter at http://twitter.com/wroush.

Comments | Reprints | Share: